Joel Gelfand of the Perelman School of Medicine comments on research that links psoriasis and diabetes.
Perelman School of Medicine
Healthy humans harbor an enormous and diverse group of bacteria and other bugs that live within their intestines. These microbial partners provide beneficial aid in multiple ways – from helping digest food to the development of a healthy immune system.
Psoriasis is an independent risk for Type 2 Diabetes, according to a new study by researchers with the Perelman School of Medicine at the University of Pennsylvania, with the greatest risk seen in patients with severe psoriasis. Researchers estimate that an additional 115,500 people will develop diabetes each year due to the risk posed by psoriasis above and beyond conventional risk factors. The research is published in the latest issue of the Archives of Dermatology, a JAMA Network publication.
Graphic Warning Labels Improve Smokers' Recall of Warning and Health Risks Related to Smoking, Penn Medicine Study Shows
In a first of its kind study in the U.S., researchers at the Perelman School of Medicine at the University of Pennsylvania have shown that the addition of graphic warning labels on cigarette packaging can improve smokers' recall of the warning and health risks associated with smoking. The new findings will be published online-first in the American Journal of Preventive Medicine.
Michael Grandner of the Perelman School of Medicine says, “It seems like foreign-born Americans may be protected by not adopting this unhealthy lifestyle.”
PHILADELPHIA — The University of Pennsylvania is now accepting applications for its Academic Diversity Postdoctoral Fellowship Program.
The program will award postdoctoral fellowships to scholars and educators from different backgrounds, races and ethnic groups and from other diverse groups whose life experience, research experience and employment background will contribute to Penn’s academic excellence. The deadline for applications is Aug. 1.
Carl June of the Perelman School of Medicine comments on the successful treatment of the world’s only cured HIV patient.
A study published this week in Cancer Cell from the Perelman School of Medicine and the Abramson Cancer Center at the University of Pennsylvania describes how pancreatic cancer cells produce a protein that attracts immune cells and tricks them into helping cancer cells grow. Blocking the protein may be also prove to be a new way to treat pancreatic cancer.